[…] homeobox 4 (DUX4) protein as a potential treatment for patients with facioscapulohumeral muscular dystrophy ( FSHD). Pending abstract acceptance, Arrowhead intends to present preclinical data on ARO-DUX4 at the 28th Annual FSHD […]
Arrowhead Pharmaceuticals announces FSHD drug candidate
“Coming out” with my FSHD diagnosis
This story about “coming out” with an FSHD diagnosis was first published in the 2014 summer issue of the FSH Watch newsletter. Its message is timeless. The #FSHDselfies campaign by […]
Join Our Los Angeles FSHD CONNECTS Meeting!
[…] Backyard 3744 Moore Street, Mar Vista, CA 90066. 1:00-5:00 PM A gathering for people with FSHD from the Los Angeles region, for networking, learning, advocacy and more! Organized by the […]
FSHD Advocate on the Road to Clinical Trials
[…] that we believe will see effective therapies become available – the families that form the FSHD Society face new challenges. This year, we have an unprecedented opportunity to participate in […]
FSHD goes to school
[…] give kids an explanation they can digest. I was casually talking to one of the FSHD team members at Fulcrum Therapeutics (a biopharma working on FSHD therapies) about our daughter’s […]